OOIR: Observatory of International Research

Papers

(The median citation count of Current Opinion in Virology is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Editorial Board	103
Monoclonal antibodies against rabies: current uses in prophylaxis and in therapy	95
Adenoviral-vectored next-generation respiratory mucosal vaccines against COVID-19	76
Hepatitis-B virus: replication cycle, targets, and antiviral approaches	73
Colonization of peripheral ganglia by herpes simplex virus type 1 and 2	65
Inhaled aerosol viral-vectored vaccines against tuberculosis	64
Transmission patterns of hepatitis E virus	58
The enigmatic roles of Anelloviridae and Redondoviridae in humans	52
Editorial Board	50
Viral–host interactions during splicing and nuclear export of influenza virus mRNAs	49
Editorial overview: Viral pathogenesis	45
Human placental models for studying viral infections	43
Virus–host protein interactions as footprints of human cytomegalovirus replication	43
Intercellular highways of viral spread: tunneling nanotubes and extracellular vesicles at the maternal–fetal interface	39
Paramyxoviruses from bats: changes in receptor specificity and their role in host adaptation	38
Editorial Board	36
The two faces of oligoadenylate synthetase-like: effective antiviral protein and negative regulator of innate immunity	34
Recent progress in development of monoclonal antibodies against human cytomegalovirus	33
Shopping for phages? Unpacking design rules for therapeutic phage cocktails	31
Emerging technologies in the study of the virome	31
Platelets in the pathogenesis of flavivirus disease	30
Epigenetic control of the Epstein-Barr lifecycle	30
Mitigation of evolved bacterial resistance to phage therapy	30
A review of broadly protective monoclonal antibodies to treat Ebola virus disease	30
A complex immune communication between eicosanoids and pulmonary macrophages	29

Engineering therapeutic phages for enhanced antibacterial efficacy	29
The enigma of picobirnaviruses: viruses of animals, fungi, or bacteria?	29
Hemagglutinin stability as a key determinant of influenza A virus transmission via air	28
Retasking of canonical antiviral factors into proviral effectors	27
Blood virome research in myalgic encephalomyelitis/chronic fatigue syndrome: challenges and opportunities	27
Human organoid models to study coronavirus infections of the respiratory tract	26
When good turns bad: how viruses exploit innate immunity factors	25
Editorial Board	25
Asymmetry in icosahedral viruses	25
Role of mucosal-associated invariant T cells in coronavirus disease 2019 vaccine immunogenicity	23
Does arbovirus emergence in humans require adaptation to domestic mosquitoes?	23
Tissue-resident memory T cells in protective immunity to influenza virus	22
Oncogenic Animal Herpesviruses	22
State-of-the-art in oncolytic virotherapy using adenoviruses other than the commonly applied adenovirus type 5	21
Modeling zoonotic and vector-borne viruses	21
MicroRNA-mediated control of Epstein–Barr virus infection and potential diagnostic and therapeutic implications	19
Immune responses to human respiratory coronaviruses infection in mouse models	19
Diagnosis and monitoring of virus-associated cancer using cell-free DNA	18
Severe fever with thrombocytopenia syndrome virus NSs: a multifaceted viral protein in host–virus interactions	17
Nexus of virus and brain: recent advances in flavivirus and enterovirus neuro-infection	17
MEK inhibitors as novel host-targeted antivirals with a dual-benefit mode of action against hyperinflammatory respiratory viral diseases	17
Nucleoside analogs for management of respiratory virus infections: mechanism of action and clinical efficacy	17
Advances in human monoclonal antibody therapy for HBV infection	16
Deimmunization of flagellin adjuvant for clinical application	16
Fruit bats as natural reservoir of highly pathogenic henipaviruses: balance between antiviral defense and viral tolerance	16
Antigenic evolution of SARS coronavirus 2	16
Role of the viral polymerase during adaptation of influenza A viruses to new hosts	16
Broadly neutralizing antibodies against COVID-19	16
Sequence variability of the K1 gene in Kaposi’s sarcoma-associated herpesvirus and its role in pathogenesis	16
Editorial overview: Virus bioinformatics - empowering genomics of pathogens, viromes, and the virosphere across divergence scales	15
Editorial Board	15
Editorial overview: Viral immunology before COVID-19	15
Editorial overview: Special issue on phage therapy	15
How and why RNA genomes are (partially) ordered in viral capsids	15
Editorial Board	15
Early signaling pathways in virus-infected cells	15
Bioinformatics of virus taxonomy: foundations and tools for developing sequence-based hierarchical classification	14
Structural insights into hepatitis C virus neutralization	14
Neutralizing monoclonal antibodies against highly pathogenic coronaviruses	14
Bacteriophage T4 as a nanovehicle for delivery of genes and therapeutics into human cells	14
Editorial overview: Engineering elimination of chronic viral hepatitis	14
Editorial overview: Anti-viral strategies: Human antibody immune response and antibody-based therapy against viruses	13
Editorial overview: Special issue on virus structure and expression in current opinion in virology	13
Host-targeted antivirals as broad-spectrum inhibitors of respiratory viruses	13
Editorial overview: Virus structure and expression	13
Advances in the treatment of HTLV-1-associated adult T-cell leukemia lymphoma	13
Broad neutralizing antibody-based strategies to tackle influenza	12
Lying low-chromatin insulation in persistent DNA virus infection	12
Editorial Board	12
Editorial Board	11

Phage therapy for secondary bacterial infections with COVID-19	11
Koala retrovirus and neoplasia: correlation and underlying mechanisms	11
Editorial overview: Viruses and cancer — challenges, breakthroughs, and future directions	10
European regulatory aspects of phage therapy: magistral phage preparations	10
Editorial Board	10
Endocytosis of Bacteriophages	9
RNA viruses and the cGAS-STING pathway: reframing our understanding of innate immune sensing	9
Therapeutic approaches to Epstein–Barr virus cancers	9
A comparative review of adenovirus A12 and C5 oncogenes	9
The role of human lipoproteins for hepatitis C virus persistence	8
Editorial Board	8
Zoonotic disease and virome diversity in bats	8
The more the merrier? Gene duplications in the coevolution of primate lentiviruses with their hosts	8
The female reproductive tract virome: understanding the dynamic role of viruses in gynecological health and disease	7
An overview of the current state of phage therapy for the treatment of biofilm-related infections	7
Editorial Board	7